Skip to Main Content

Paper Details

Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.
Clin Cancer Res
34
2011
Aromatase, Cancer, ER, Hip fractures, adriamycin, anastrozole, bone loss, breast cancer, cancer, cytoxan, fractures, hip and femur fractures, hip fractures, hip or femur fractures, malignancy, osteopenia, osteoporosis, patients, tamoxifen, women
Author NameAffiliation
Beatrice J EdwardsFeinberg School of Medicine, Northwestern University
  • 1 - 1

Datasets

Dataset
Description
Source Link
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
Release 1.2